| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13190* | 2021 |
| Pancreatic cancer D Li, K Xie, R Wolff, JL Abbruzzese The Lancet 363 (9414), 1049-1057, 2004 | 2717 | 2004 |
| The Beclin 1 network regulates autophagy and apoptosis R Kang, HJ Zeh, MT Lotze, D Tang Cell Death & Differentiation 18 (4), 571-580, 2011 | 2635 | 2011 |
| Autophagy promotes ferroptosis by degradation of ferritin W Hou, Y Xie, X Song, X Sun, MT Lotze, HJ Zeh III, R Kang, D Tang Autophagy 12 (8), 1425-1428, 2016 | 1544 | 2016 |
| PAMP s and DAMP s: Signal 0s that spur autophagy and immunity D Tang, R Kang, CB Coyne, HJ Zeh, MT Lotze Immunological reviews 249 (1), 158-175, 2012 | 1410 | 2012 |
| Endogenous HMGB1 regulates autophagy D Tang, R Kang, KM Livesey, CW Cheh, A Farkas, P Loughran, G Hoppe, ... Journal of Cell Biology 190 (5), 881-892, 2010 | 1041 | 2010 |
| HMGB1 in health and disease R Kang, R Chen, Q Zhang, W Hou, S Wu, L Cao, J Huang, Y Yu, X Fan, ... Molecular aspects of medicine 40, 1-116, 2014 | 965 | 2014 |
| The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity MT Lotze, HJ Zeh, A Rubartelli, LJ Sparvero, AA Amoscato, NR Washburn, ... Immunological reviews 220 (1), 60-81, 2007 | 785 | 2007 |
| RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation LJ Sparvero, D Asafu-Adjei, R Kang, D Tang, N Amin, J Im, R Rutledge, ... Journal of translational medicine 7, 1-21, 2009 | 726 | 2009 |
| The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity Y Xie, S Zhu, X Song, X Sun, Y Fan, J Liu, M Zhong, H Yuan, L Zhang, ... Cell reports 20 (7), 1692-1704, 2017 | 703 | 2017 |
| Induction of CD8+ T-cell responses against novel glioma–associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and … H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ... Journal of clinical oncology 29 (3), 330, 2011 | 681 | 2011 |
| High-mobility group box 1 and cancer D Tang, R Kang, HJ Zeh III, MT Lotze Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799 (1-2 …, 2010 | 671 | 2010 |
| Safety and survival with GVAX pancreas prime and Listeria monocytogenes–expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer DT Le, A Wang-Gillam, V Picozzi, TF Greten, T Crocenzi, G Springett, ... Journal of clinical Oncology 33 (12), 1325, 2015 | 637 | 2015 |
| High-mobility group box 1, oxidative stress, and disease D Tang, R Kang, HJ Zeh III, MT Lotze Antioxidants & redox signaling 14 (7), 1315-1335, 2011 | 580 | 2011 |
| HMGB1 in cancer: good, bad, or both? R Kang, Q Zhang, HJ Zeh III, MT Lotze, D Tang Clinical cancer research 19 (15), 4046-4057, 2013 | 533 | 2013 |
| Arginine and immunity PJ Popovic, HJ Zeh III, JB Ochoa The Journal of nutrition 137 (6), 1681S-1686S, 2007 | 528 | 2007 |
| AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system Xc–activity X Song, S Zhu, P Chen, W Hou, Q Wen, J Liu, Y Xie, J Liu, DJ Klionsky, ... Current Biology 28 (15), 2388-2399. e5, 2018 | 522 | 2018 |
| HMGB1 release and redox regulates autophagy and apoptosis in cancer cells D Tang, R Kang, CW Cheh, KM Livesey, X Liang, NE Schapiro, ... Oncogene 29 (38), 5299-5310, 2010 | 522 | 2010 |
| High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy HJ Zeh, D Perry-Lalley, ME Dudley, SA Rosenberg, JC Yang The Journal of Immunology 162 (2), 989-994, 1999 | 506 | 1999 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement J Esquivel, R Sticca, P Sugarbaker, E Levine, TD Yan, R Alexander, ... Annals of surgical oncology 14, 128-133, 2007 | 496 | 2007 |
